1. Home /
  2. Healthcare

Healthcare

Arianna Huffington on Burnout, Tech-Life Balance and Why Amazon's CEO Agrees

Arianna Huffington on Burnout, Tech-Life Balance and Why Amazon's CEO Agrees

Alpha Rising spent time with Thrive Global founder & CEO Arianna Huffington to talk about why corporations need to address burnout and stress if they want to succeed and why Amazon's Jeff Bezos agrees. Watch!

GE Investors Brace for Disaster, Will Settle for Disappointment

GE Investors Brace for Disaster, Will Settle for Disappointment

GE has restated its financials for the past two years, faces a massive $31 billion pension deficit, has liquidity concerns rising from the long-term health obligations of its largely divested GE Capital unit and will likely revise earnings guidance down for the year. Investors probably can't handle much more.

Ultragenyx Pharmaceutical Wins Approval for Drug Treating Rare Form of Rickets

Ultragenyx Pharmaceutical Wins Approval for Drug Treating Rare Form of Rickets

Ultragenyx scored its second FDA drug approval in six months. The orphan disease specialist also picked up its second Rare Pediatric Disease Priority Review Voucher; its first sold for $130 million.

Glucose Monitoring Device in Focus as Abbott Preps to Unveil Earnings

Glucose Monitoring Device in Focus as Abbott Preps to Unveil Earnings

Abbott's Freestyle Libre in September secured FDA approval and in January, the company said the device had received reimbursement from the Centers for Medicare & Medicaid Services.

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists

Jim Cramer and our other experts discuss Netflix and the FANGS, stock picking rewarded, and a way to hide from political risk.

Here's What to Watch as UnitedHealth Reports Earnings on Tuesday

Here's What to Watch as UnitedHealth Reports Earnings on Tuesday

The company's underwriting margins and traditional health insurance business are key areas to watch, according to BMO Capital Markets' Matthew Borsch.

Merck Notches Key Win Over Bristol-Myers on Lung Cancer Study Data

Merck Notches Key Win Over Bristol-Myers on Lung Cancer Study Data

The drugmakers on April 16 released data from their respective studies at the Association for Cancer Research's annual meeting in Chicago.

Shire Plans $2.4 Billion Oncology Business Sale to France's Servier SAS

Shire Plans $2.4 Billion Oncology Business Sale to France's Servier SAS

Shire will sell its oncology business to France's Servier for around $2.4 billion as it contemplates a possible $50 billion takeover from Japan's Takeda Pharmaceutical Co.

In Biopharma M&A, 'Where There's Real Innovation There's Someone Willing to Pay'

In Biopharma M&A, 'Where There's Real Innovation There's Someone Willing to Pay'

Deals in biopharma slowed in 2017 for the third consecutive year. According to Intec Pharma CEO Jeffrey Meckler, just because volume is down doesn't mean it's out.

Mylan's Stock Gets Bump After Investor Day

Mylan's Stock Gets Bump After Investor Day

Following Wednesday's event, Leerink analyst Ami Fadia said she is 'incrementally more positive' on the drugmaker's pipeline and diversified business model and moved her rating to outperform.